These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 16838598)

  • 21. A framework for monitoring of new drugs in Sweden.
    Cars T; Lindhagen L; Sundström J
    Ups J Med Sci; 2019 Jan; 124(1):46-50. PubMed ID: 30689485
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Pharmacoepidemiology].
    Hallas J; Sørensen HT
    Ugeskr Laeger; 2005 May; 167(20):2186-90. PubMed ID: 15987081
    [No Abstract]   [Full Text] [Related]  

  • 23. The challenges of globalization in pharmaceutical law--is an international drug approval system modeled after the European system worth considering?
    Purnhagen KP
    Food Drug Law J; 2008; 63(3):623-45. PubMed ID: 19031663
    [No Abstract]   [Full Text] [Related]  

  • 24. The International Society of Pharmacovigilance.
    Edwards R
    Pharmacoepidemiol Drug Saf; 2002; 11(3):253-4. PubMed ID: 12051125
    [No Abstract]   [Full Text] [Related]  

  • 25. [The decisive steps cost billions. Extensive studies provide answers for many questions].
    Wallström A; Rosén A; Keisu M
    Lakartidningen; 1997 Jul; 94(30-31):2653-7. PubMed ID: 9273428
    [No Abstract]   [Full Text] [Related]  

  • 26. International Conference on Harmonisation; guidance on Q10 Pharmaceutical Quality System; availability. Notice.
    Food and Drug Administration, HHS
    Fed Regist; 2009 Apr; 74(66):15990-1. PubMed ID: 19507321
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Drug vigilance].
    Imbs JL; Welsch M
    Rev Prat; 2002 Mar; 52(5):502-6. PubMed ID: 11949502
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Global harmonization is not all that global: divergent approaches in drug safety.
    Castle GH; Kelly B
    Food Drug Law J; 2008; 63(3):601-22. PubMed ID: 19031662
    [No Abstract]   [Full Text] [Related]  

  • 29. Statistical aspects in comparative benefit-risk assessment: challenges and opportunities for pharmaceutical statisticians.
    Quartey G; Wang J
    Pharm Stat; 2012; 11(1):82-5. PubMed ID: 21997832
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dunkel proposals and the medical profession.
    Roy UK
    J Indian Med Assoc; 1993 Nov; 91(11):295-6. PubMed ID: 8138655
    [No Abstract]   [Full Text] [Related]  

  • 31. Vioxx, radiology, and the Food and Drug Administration.
    Pentecost MJ
    J Am Coll Radiol; 2005 May; 2(5):394-7. PubMed ID: 17411841
    [No Abstract]   [Full Text] [Related]  

  • 32. U.S. postmarketing pharmacovigilance compliance in the midst of regulatory uncertainty.
    Goldman SA
    Food Drug Law J; 2007; 62(3):513-28. PubMed ID: 17915393
    [No Abstract]   [Full Text] [Related]  

  • 33. [Marketing of pediatric drugs].
    Pabst JY
    Soins Pediatr Pueric; 2003; (210):18-9. PubMed ID: 12683130
    [No Abstract]   [Full Text] [Related]  

  • 34. [Increased significance of adverse effects of drugs--a threat to the industry].
    Werkö L
    Lakartidningen; 2004 Dec; 101(50):4134-6. PubMed ID: 15631270
    [No Abstract]   [Full Text] [Related]  

  • 35. [Time, medical records and quality assurance--the cost-benefit assessment is a must].
    Ericsson M
    Lakartidningen; 2000 May; 97(18):2245-6. PubMed ID: 10850056
    [No Abstract]   [Full Text] [Related]  

  • 36. [The prescription registry must be used correctly: quality improvement--not a basis for sanctions].
    Eliasson G
    Lakartidningen; 1996 Mar; 93(13):1197-8. PubMed ID: 8656830
    [No Abstract]   [Full Text] [Related]  

  • 37. Free access to pharmacovigilance data.
    Prescrire Int; 2006 Aug; 15(84):138. PubMed ID: 16991216
    [No Abstract]   [Full Text] [Related]  

  • 38. Strategy for surveillance of adverse drug events.
    Bright RA
    Food Drug Law J; 2007; 62(3):605-16. PubMed ID: 17915403
    [No Abstract]   [Full Text] [Related]  

  • 39. Legalized importation of Canadian prescription drugs: short-term solution to a long-term problem.
    Teufel AT
    J Contemp Health Law Policy; 2006; 22(2):383-408. PubMed ID: 17117702
    [No Abstract]   [Full Text] [Related]  

  • 40. The US drug safety system: role of the pharmaceutical industry.
    Gibson BR; Suh R; Tilson H
    Pharmacoepidemiol Drug Saf; 2008 Feb; 17(2):110-4. PubMed ID: 17724741
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.